NDC 16714-770

Rasagiline

Rasagiline

Rasagiline is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Northstar Rxllc. The primary component is Rasagiline Mesylate.

Product ID16714-770_3295bc62-c840-437e-9b44-d9a04fda95cf
NDC16714-770
Product TypeHuman Prescription Drug
Proprietary NameRasagiline
Generic NameRasagiline
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2018-04-17
Marketing CategoryANDA / ANDA
Application NumberANDA201889
Labeler NameNorthStar RxLLC
Substance NameRASAGILINE MESYLATE
Active Ingredient Strength1 mg/1
Pharm ClassesMonoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 16714-770-01

30 TABLET in 1 BOTTLE (16714-770-01)
Marketing Start Date2018-04-17
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 16714-770-01 [16714077001]

Rasagiline TABLET
Marketing CategoryANDA
Application NumberANDA201889
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-04-17

Drug Details

Active Ingredients

IngredientStrength
RASAGILINE MESYLATE.5 mg/1

OpenFDA Data

SPL SET ID:8bf8e76c-27cb-42a4-aa9c-bdade68c463b
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 608328
  • 636664
  • UPC Code
  • 0316714770017
  • 0316714771014
  • Pharmacological Class

    • Monoamine Oxidase Inhibitor [EPC]
    • Monoamine Oxidase Inhibitors [MoA]

    Medicade Reported Pricing

    16714077001 RASAGILINE MESYLATE 0.5 MG TAB

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Rasagiline" or generic name "Rasagiline"

    NDCBrand NameGeneric Name
    0093-3060RasagilineRasagiline
    0093-3061RasagilineRasagiline
    16714-770RasagilineRasagiline
    16714-771RasagilineRasagiline
    42291-779RasagilineRasagiline
    42291-780RasagilineRasagiline
    42571-220RASAGILINERasagiline
    42571-221RASAGILINERasagiline
    47781-683RasagilineRasagiline
    47781-690RasagilineRasagiline
    67877-259RasagilineRasagiline
    67877-260RasagilineRasagiline

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.